Top Markets
Coin of the day
Impact BioMedical Inc. Impact BioMedical Inc.

Impact BioMedical Inc.

IBO
Classifica tra le azioni #25451
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Prezzo delle azioni
$0.4587
Ultima sincronizzazione: 2026-08-20
Capitalizzazione di mercato
$49.46M
Variazione (1 giorno)
5.89%
Variazione (1 anno)
-22.83%
Paese
US
Scambia Impact BioMedical Inc. (IBO)

Categoria

Storico del prezzo dell'azione per Impact BioMedical Inc. (IBO)
Prezzo di chiusura più alto: $0.45 il 2026-08-01

Prezzo di chiusura più basso: $2.36 il 2024-09-01
Storico del prezzo dell'azione di Impact BioMedical Inc. dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 10.03%
2025 -74.29%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US